Dong-A Pharmaceutical Co.,Ltd.

₩87,000As of Sun 8 Nov 2026, 12:00 UTC
KRX:000640Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (3.13%)
Div yield 1.90%
ROE 7.32%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.14
PE TTM 7.863
TSR TTM (15.95%)
Mkt cap ₩585.5B
ROIC 6.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩86,647
(0.41%)
(91.24%)
Hold 1|1|9|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
1,684
1,841
2,050
1,949
6.47%
11.82%
22.22%
14.03%
Revenue₩B
67.98
68.53
67.26
66.31
3.92%
(0.07%)
0.74%
0.30%
Peers (US$431.7M)
Cap (US$)
PE
529.1M
5.939x
499.0M
3.720x
380.5M
5.484x
433.3M
17.80x
Capital
TTM
5Y
10Y
Leveragex
0.841
2.523
1.798
EBIT/Intx
1.213
1.166
0.842
Own earn%
(171.48)
31.47
31.37
Sh yield%
14.65
48.18
48.20
Owners
Insiders/Inst%
3.53
37.57
Short interest%
2.90
SBC / revenue%
2.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
3–12
$1 testx
—
Incr. ROIC%
5